| Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma A Mackay, A Burford, D Carvalho, E Izquierdo, J Fazal-Salom, KR Taylor, ... Cancer cell 32 (4), 520-537. e5, 2017 | 854 | 2017 |
| Non–small cell lung cancer: histopathologic correlates for texture parameters at CT B Ganeshan, V Goh, HC Mandeville, QS Ng, PJ Hoskin, KA Miles Radiology 266 (1), 326-336, 2013 | 485 | 2013 |
| Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells M Vinci, A Burford, V Molinari, K Kessler, S Popov, M Clarke, KR Taylor, ... Nature medicine 24 (8), 1204-1215, 2018 | 166 | 2018 |
| Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial G Bisogno, M Jenney, C Bergeron, SG Melcón, A Ferrari, O Oberlin, ... The Lancet Oncology 19 (8), 1061-1071, 2018 | 162 | 2018 |
| Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: a matched-cohort analysis on behalf of the SIOP-E-HGG … GO Janssens, L Gandola, S Bolle, H Mandeville, M Ramos-Albiac, ... European journal of cancer 73, 38-47, 2017 | 145 | 2017 |
| An emerging evidence base for PET-CT in the management of childhood rhabdomyosarcoma: systematic review G Norman, D Fayter, K Lewis-Light, J Chisholm, K McHugh, D Levine, ... BMJ open 5 (1), e006030, 2015 | 84 | 2015 |
| Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma … QS Ng, H Mandeville, V Goh, R Alonzi, J Milner, D Carnell, K Meer, ... Annals of oncology 23 (1), 231-237, 2012 | 69 | 2012 |
| Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group BA Hoeben, C Carrie, B Timmermann, HC Mandeville, L Gandola, ... The Lancet Oncology 20 (3), e155-e166, 2019 | 68 | 2019 |
| Consensus report from the Stockholm pediatric proton therapy conference DJ Indelicato, T Merchant, N Laperriere, Y Lassen, S Vennarini, S Wolden, ... International journal of radiation oncology, biology, physics 96 (2), 387-392, 2016 | 64 | 2016 |
| Fusion status in patients with lymph node‐positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue … S Gallego, I Zanetti, D Orbach, D Ranchère, J Shipley, A Zin, C Bergeron, ... Cancer 124 (15), 3201-3209, 2018 | 63 | 2018 |
| Radiation dose from volumetric helical perfusion CT of the thorax, abdomen or pelvis V Goh, M Dattani, J Farwell, J Shekhdar, E Tam, S Patel, J Juttla, ... European radiology 21, 974-981, 2011 | 59 | 2011 |
| Non-coplanar trajectories to improve organ at risk sparing in volumetric modulated arc therapy for primary brain tumors G Smyth, PM Evans, JC Bamber, HC Mandeville, LC Welsh, FH Saran, ... Radiotherapy and Oncology 121 (1), 124-131, 2016 | 58 | 2016 |
| A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations SL George, E Izquierdo, J Campbell, E Koutroumanidou, P Proszek, ... European Journal of Cancer 121, 224-235, 2019 | 54 | 2019 |
| Adverse events of local treatment in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment RA Schoot, O Slater, CM Ronckers, AH Zwinderman, AJM Balm, B Hartley, ... European Journal of Cancer 51 (11), 1424-1434, 2015 | 53 | 2015 |
| Operable non–small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia HC Mandeville, QS Ng, FM Daley, PR Barber, G Pierce, J Finch, M Burke, ... Radiology 264 (2), 581-589, 2012 | 53 | 2012 |
| Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma SL George, N Falzone, S Chittenden, SJ Kirk, D Lancaster, SJ Vaidya, ... Nuclear medicine communications 37 (5), 466-472, 2016 | 44 | 2016 |
| Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma F Carceller, LA Fowkes, K Khabra, L Moreno, F Saran, A Burford, ... Journal of neuro-oncology 129, 109-121, 2016 | 41 | 2016 |
| Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma SC Clement, RA Schoot, O Slater, JC Chisholm, C Abela, AJM Balm, ... European Journal of Cancer 54, 1-10, 2016 | 39 | 2016 |
| Ten challenges in the management of neuroblastoma J Gains, H Mandeville, N Cork, P Brock, M Gaze Future oncology 8 (7), 839-858, 2012 | 37 | 2012 |
| Initial UK experience of stereotactic body radiotherapy for extracranial oligometastases: can we change the therapeutic paradigm? K Aitken, A Tree, K Thomas, C Nutting, M Hawkins, D Tait, H Mandeville, ... Clinical Oncology 27 (7), 411-419, 2015 | 36 | 2015 |
